SENORES PHARMACEUTICALS
Back to Cashflow Statement
|
SENORES PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.33 Cr | ₹573 Cr | ₹87 Cr | ₹46 Cr | ₹36 Cr |
What is the latest Cash Flow from Financing Activities ratio of SENORES PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-1.33 Cr |
| Mar2025 | ₹573 Cr |
| Mar2024 | ₹87 Cr |
| Mar2023 | ₹46 Cr |
| Mar2022 | ₹36 Cr |
How is Cash Flow from Financing Activities of SENORES PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1.33 Cr | Negative | |
| Mar2025 | ₹573 Cr | 558.92 | |
| Mar2024 | ₹87 Cr | 88.06 | |
| Mar2023 | ₹46 Cr | 26.84 | |
| Mar2022 | ₹36 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SENORES PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SENORES PHARMACEUTICALS | ₹5,250.1 Cr | -2.8% | -13.4% | 47.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,688.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹295,080.0 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,677.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,852.0 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| CIPLA | ₹111,731.0 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
SENORES PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SENORES PHARMACEUTICALS | -2.8% |
-13.4% |
47.5% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses